Mediator complex subunit 12 (MED12) (MED12)

Mediator complex subunit 12 (MED12) is a core component of the Mediator complex kinase module, which plays a fundamental role in regulating RNA polymerase II-mediated transcription across the human genome [1]. In the context of immunology, MED12 has been identified as a potent negative regulator of Natural Killer (NK) cell effector functions [2]. Research indicates that MED12 restricts the expression of genes essential for NK cell activation and cytotoxicity; consequently, its genetic deletion or inhibition significantly boosts the anti-tumor response of NK cells [3]. This makes MED12 a high-priority target for genetic engineering in adoptive cell therapies, such as CAR-NK cells, to overcome the immunosuppressive tumor microenvironment [2]. Beyond its role in immune cells, MED12 is implicated in various pathologies, including uterine leiomyomas and certain X-linked intellectual disability syndromes, highlighting its broad biological significance [4, 5].

Other names

HOPAKRGOPA1TRAP230Mediator complex subunit 12

Enhancement of NK cell cytotoxicity through the transcriptional derepression of effector genes following MED12 deletion or inhibition.